Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection (Q85007388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1 reference

1 reference

Clostridium difficile

object named as

Clostridium difficile

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

C Lemire

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Ruel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A M Cantin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

F Ménard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

L Valiquette

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

21 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

579-582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22996384%20AND%20SRC:MED&resulttype=core&format=json

Perioperative anaphylaxis from locally applied rifamycin SV and latex.

13 February 2020

cites work

1 reference

12 December 2020

An elderly woman with 'Red Man Syndrome' in association with oral vancomycin therapy: a case report

1 reference

12 December 2020

Failure of tigecycline to treat severe Clostridium difficile infection

1 reference

12 December 2020

Anaphylaxis to topical bacitracin ointment

1 reference

12 December 2020

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin

1 reference

12 December 2020

Allergic reactions associated with airborne fish particles in IgE-mediated fish hypersensitive patients

1 reference

12 December 2020

Multiple drug allergy syndrome: severe anaphylactic reaction due to topical rifamycin SV in a patient with hypersensitivity to ciprofloxacin.

1 reference

12 December 2020

Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

1 reference

12 December 2020

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

1 reference

12 December 2020

Studies on the mechanism of multiple drug allergies. Structural basis of drug recognition

1 reference

12 December 2020

Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection

1 reference

12 December 2020

Factors affecting the determination of threshold doses for allergenic foods: how much is too much?

1 reference

12 December 2020

Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.

1 reference

12 December 2020

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.

1 reference

12 December 2020

Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions.

1 reference

12 December 2020

OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection

1 reference

12 December 2020

Maculopapular rash induced by oral vancomycin

1 reference

12 December 2020

Possible red-man syndrome associated with systemic absorption of oral vancomycin in a child with normal renal function

1 reference

12 December 2020

Antibiotic hypersensitivity in patients with CF.

1 reference

12 December 2020

Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.

1 reference

12 December 2020

Intravenous tigecycline in the treatment of severe recurrent Clostridium difficile colitis

1 reference

12 December 2020

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection

1 reference

12 December 2020

Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole

1 reference

12 December 2020

Both oral metronidazole and oral vancomycin promote persistent overgrowth of vancomycin-resistant enterococci during treatment of Clostridium difficile-associated disease

1 reference

12 December 2020

Anaphylaxis to topical bacitracin zinc ointment

1 reference

12 December 2020

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

1 reference

12 December 2020